Gores GJ - Search Results

1

Apoptosis and cellular activation in the pathogenesis of acute vascular rejection.

Holzknecht ZE, Kuypers KL, Plummer TB, Williams J, Bustos M, Gores GJ, Brunn GJ, Platt JL. Holzknecht ZE, et al. Among authors: gores gj. Circ Res. 2002 Dec 13;91(12):1135-41. doi: 10.1161/01.res.0000046236.20251.fa. Circ Res. 2002. PMID: 12480814

2

Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.

Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH, Gores GJ. Taniai M, et al. Among authors: gores gj. Cancer Res. 2004 May 15;64(10):3517-24. doi: 10.1158/0008-5472.CAN-03-2770. Cancer Res. 2004. PMID: 15150106

3

Apoptosis and necrosis in the liver.

Guicciardi ME, Malhi H, Mott JL, Gores GJ. Guicciardi ME, et al. Among authors: gores gj. Compr Physiol. 2013 Apr;3(2):977-1010. doi: 10.1002/cphy.c120020. Compr Physiol. 2013. PMID: 23720337 Free PMC article. Review.

4

Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation.

van Hoek B, Wiesner RH, Ludwig J, Gores GJ, Moore B, Krom RA. van Hoek B, et al. Among authors: gores gj. Transplant Proc. 1991 Feb;23(1 Pt 2):1403-5. Transplant Proc. 1991. PMID: 1989248 No abstract available.

5

Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue.

Sandborn WJ, Lawson GM, Cody TJ, Porayko MK, Hay JE, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: gores gj. Hepatology. 1995 Jan;21(1):70-6. Hepatology. 1995. PMID: 7528712 Clinical Trial.

6

Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.

Wiesner RH, Porayko MK, Wahlstrom HE, Gores GJ, Kamath PS, Hay JE, Krom RA. Wiesner RH, et al. Among authors: gores gj. Transplant Proc. 1993 Apr;25(2):1791-3. Transplant Proc. 1993. PMID: 7682352 Clinical Trial. No abstract available.

7

Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipients.

Ninova DI, Wiesner RH, Gores GJ, Harrison JM, Krom RA, Homburger HA. Ninova DI, et al. Among authors: gores gj. J Hepatol. 1994 Dec;21(6):1080-5. doi: 10.1016/s0168-8278(05)80621-x. J Hepatol. 1994. PMID: 7699231

8

Treatment of early cellular rejection following liver transplantation with intravenous methylprednisolone. The effect of dose on response.

Wiesner RH, Ludwig J, Krom RA, Steers JL, Porayko MK, Gores GJ, Hay JE. Wiesner RH, et al. Among authors: gores gj. Transplantation. 1994 Nov 15;58(9):1053-6. doi: 10.1097/00007890-199411150-00015. Transplantation. 1994. PMID: 7974734 No abstract available.

9

Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.

Sandborn WJ, Hay JE, Porayko MK, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: gores gj. Hepatology. 1994 Apr;19(4):925-32. Hepatology. 1994. PMID: 8138267

10

The role of proteases during apoptosis.

Patel T, Gores GJ, Kaufmann SH. Patel T, et al. Among authors: gores gj. FASEB J. 1996 Apr;10(5):587-97. doi: 10.1096/fasebj.10.5.8621058. FASEB J. 1996. PMID: 8621058 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

688 results

Search Page